Chemed Corp. (CHE) Tops Q2 EPS by 2c, Posts Strong Full Year Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Price: $511.37 -0.91%
EPS Growth %: +22.2%
Financial Fact:
Net income: 1.62
Today's EPS Names:
FNLC, LSBK, OVLY, More
EPS Growth %: +22.2%
Financial Fact:
Net income: 1.62
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
Chemed Corp. (NYSE: CHE) reported Q2 EPS of $1.09, $0.02 better than the analyst estimate of $1.07. Revenue for the quarter came in at $333 million versus the consensus estimate of $336.35 million.
Chemed Corp. sees FY2011 EPS of $4.70-$4.80, versus the consensus of $4.34.
Chemed Corp. sees FY2011 EPS of $4.70-$4.80, versus the consensus of $4.34.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integra LifeSciences (IART) Tops Q3 EPS by 3c; offers guidance
- Oak Valley Bancorp (OVLY) Tops Q3 EPS by 77c
- Medpace beats Q3 estimates but guides below on revenue
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
